Public-registry site landscape for NCT04286438, a Hemorrhage study sponsored by SFJ Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04286438 (registry record) |
| Sponsor | SFJ Pharmaceuticals, Inc. |
| Condition(s) | Hemorrhage; Urgent Surgery; Invasive Procedure |
| Phase | PHASE3 |
| Listed sites | 68 |
| Site countries | United States, Austria, Belgium, Canada, China, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland |
Eichor generates a preliminary site-risk snapshot for NCT04286438 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →